Your browser does not allow JavaScript!
JavaScript is necessary for the proper functioning of this website. Please enable JavaScript or use a modern browser.
Repository of the University of Ljubljana
Open Science Slovenia
Open Science
DiKUL
slv
|
eng
Search
Browse
New in RUL
About RUL
In numbers
Help
Sign in
Details
The structural features of novel bacterial topoisomerase inhibitors that define their activity on topoisomerase IV
ID
Kokot, Maja
(
Author
),
ID
Anderluh, Marko
(
Author
),
ID
Hrast, Martina
(
Author
),
ID
Minovski, Nikola
(
Author
)
PDF - Presentation file,
Download
(5,07 MB)
MD5: E7BE7C5FBF565F032561CBA64E64B6A3
URL - Source URL, Visit
https://pubs.acs.org/doi/10.1021/acs.jmedchem.2c00039
Image galllery
Abstract
The continued emergence of bacterial resistance has created an urgent need for new and effective antibacterial agents. Bacterial type II topoisomerases, such as DNA gyrase and topoisomerase IV (topoIV), are well-validated targets for antibacterial chemotherapy. The novel bacterial topoisomerase inhibitors (NBTIs) represent one of the new promising classes of antibacterial agents. They can inhibit both of these bacterial targets; however, their potencies differ on the targets among species, making topoIV probably a primary target of NBTIs in Gram-negative bacteria. Therefore, it is important to gain an insight into the NBTIs key structural features that govern the topoIV inhibition. However, in Gram-positive bacteria, topoIV is also a significant target for achieving dual-targeting, which in turn contributes to avoiding bacterial resistance caused by single-target mutations. In this perspective, we address the structure–activity relationship guidelines for NBTIs that target the topoIV enzyme in Gram-positive and Gram-negative bacteria.
Language:
English
Keywords:
genetics
,
inhibition
,
bacteria
,
phenyls
Work type:
Article
Typology:
1.02 - Review Article
Organization:
FFA - Faculty of Pharmacy
Publication status:
Published
Publication version:
Version of Record
Year:
2022
Number of pages:
Str. 6431–6440
Numbering:
Vol. 65, iss. 9
PID:
20.500.12556/RUL-140640
UDC:
615.4:54:615.015.8
ISSN on article:
0022-2623
DOI:
10.1021/acs.jmedchem.2c00039
COBISS.SI-ID:
106691587
Publication date in RUL:
16.09.2022
Views:
677
Downloads:
235
Metadata:
Cite this work
Plain text
BibTeX
EndNote XML
EndNote/Refer
RIS
ABNT
ACM Ref
AMA
APA
Chicago 17th Author-Date
Harvard
IEEE
ISO 690
MLA
Vancouver
:
Copy citation
Share:
Record is a part of a journal
Title:
Journal of medicinal chemistry
Shortened title:
J. med. chem.
Publisher:
American Chemical Society
ISSN:
0022-2623
COBISS.SI-ID:
25763328
Licences
License:
CC BY 4.0, Creative Commons Attribution 4.0 International
Link:
http://creativecommons.org/licenses/by/4.0/
Description:
This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Secondary language
Language:
Slovenian
Keywords:
farmacevtska kemija
,
bakterijska rezistenca
Projects
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0017
Name:
Modeliranje kemijskih procesov in lastnosti spojin
Funder:
ARRS - Slovenian Research Agency
Project number:
P1-0208
Name:
Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin
Funder:
ARRS - Slovenian Research Agency
Funding programme:
Young researchers
Similar documents
Similar works from RUL:
Similar works from other Slovenian collections:
Back